FDA approves new indication for drug to treat severe COVID-19

FDA approves new indication for drug to treat severe COVID-19

Submitted by admin on May 12, 2022 - 10:51pm
Source: 
Beckers Hospital Review
News Tags: 
Eli Lilly
Incyte
baricitinib
FDA
olumiant
COVID-19
Headline: 
FDA approves new indication for drug to treat severe COVID-19
snippet: 

The FDA on May 11 approved Eli Lilly and partner Incyte's baricitinib, which goes by the brand name Olumiant, to treat COVID-19 in certain hospitalized adults.

Do Not Allow Advertisers to Use My Personal information